These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10455354)

  • 1. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications.
    Jindra P; Koza V; Fiser J; Vozobulová V; Svojgrová M
    Bone Marrow Transplant; 1999 Jul; 24(2):215-7. PubMed ID: 10455354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
    Vick DJ; Byrd JC; Beal CL; Chaffin DJ
    Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
    Lysak D; Koza V; Steinerova K; Jindra P; Vozobulova V; Schutzova M
    Ann Hematol; 2005 Jul; 84(7):456-61. PubMed ID: 15770494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmanipulated peripheral blood stem cell autograft in chronic lymphocytic leukemia: clinical findings and biological monitoring.
    Meloni G; Proia A; Mauro F; Amaranto P; Capria S; Cimino G; Cordone I; de Fabritiis P; Rapanotti C; Reato G; Vignetti M; Foa R; Mandelli F
    Haematologica; 2000 Sep; 85(9):952-60. PubMed ID: 10980634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
    Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
    Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose intensification and molecular responses in patients with chronic lymphocytic leukaemia: a phase II single centre study.
    Schey S; Ahsan G; Jones R
    Bone Marrow Transplant; 1999 Nov; 24(9):989-93. PubMed ID: 10556958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation.
    Patriarca F; Gaidano G; Capello D; Zaja F; Fanin R; Baccarani M
    Haematologica; 2000 Sep; 85(9):982-5. PubMed ID: 10980639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.
    Jantunen E; Itälä M; Siitonen T; Kuittinen T; Heiskanen J; Koivunen E; Juvonen E; Silvennoinen R; Nousiainen T; Koistinen P; Volin L; Remes K
    Bone Marrow Transplant; 2008 Feb; 41(3):239-44. PubMed ID: 17968327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation.
    Jindra P; Koza V; Boudová L; Vozobulová V; Cerná K; Karas M; Lysák D; Svojgrová M
    Bone Marrow Transplant; 2003 May; 31(10):951-2. PubMed ID: 12748677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield.
    Itälä M; Pelliniemi TT; Rajamäki A; Remes K
    Bone Marrow Transplant; 1997 Apr; 19(7):647-51. PubMed ID: 9156240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
    Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
    Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic lymphocytic leukemia. 2. Therapy].
    Hallek M; Schmitt B; Emmerich B; Stein H
    Dtsch Med Wochenschr; 2001 Jun; 126(23):690-5. PubMed ID: 11441667
    [No Abstract]   [Full Text] [Related]  

  • 19. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
    Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
    Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP).
    Michallet M; Thiébaut A; Dreger P; Remes K; Milpied N; Santini G; Hamon M; Björkstrand B; Kimby E; Belhabri A; Tanguy ML; Apperley JF
    Br J Haematol; 2000 Mar; 108(3):595-601. PubMed ID: 10759719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.